Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

European Society
For Medical Oncology

ESMO-Congress-2023-1000x250-Register-Now
Meet us in Madrid, Spain, or Online
Meet us in Madrid, Spain, or Online

ESMO Congress 2023

Almost all late-breaking abstract authors and titles are online. Check the programme and register now!

Register now
ESMO-MCBS 1000x1000

ESMO-MCBS

A validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.

Discover more

Latest News

Press Releases Event Announcement

Molecular Analysis for Precision Oncology Congress 2023, 4–6 October 2023 Paris, France

The Molecular Analysis for Precision Oncology Congress 2023 (MAP) is the appointment where experts present the latest developments and discuss the present and future of the rapidly evolving field of precision oncology, whose aim is to identify genomic alterations to provide the best possible personalised treatment to patients with cancer. 

More Oncology News More Press Releases More Society Updates Read the ESMO Daily Reporter
More Oncology News
Press Releases Event Announcement

Molecular Analysis for Precision Oncology Congress 2023, 4–6 October 2023 Paris, France

The Molecular Analysis for Precision Oncology Congress 2023 (MAP) is the appointment where experts present the latest developments and discuss the present and future of the rapidly evolving field of precision oncology, whose aim is to identify genomic alterations to provide the best possible personalised treatment to patients with cancer. 

Press Releases Event Announcement

ESMO Breast Cancer Congress 2023

The ESMO Breast Cancer Congress 2023, will be held onsite in Berlin, Germany, and online, through a virtual platform, between 11-13 May 2023

Press Releases Event Announcement

ESMO Targeted Anticancer Therapies Congress 2023

The ESMO Targeted Anticancer Therapies Congress 2023, the gathering focusing on promising new anticancer targets and agents, with a particular emphasis on those in early phase clinical development, will be held in Paris, France, on 6-8 March 2023.

Press Releases Event Announcement

ESMO Gynaecological Cancers Congress 2023

The ESMO Gynaecological Cancers Congress 2023, the annual event dedicated to improving the practice of gynaecological cancers specialists worldwide, will provide an overview of the latest treatments as well as insights into the biology and biomarkers of ovarian, uterine, cervical and even rare gynaecological cancers.

More Press Releases
Society Updates Society Updates

New ESMO Journals

Committed to delivering high-quality medical science and to helping the oncology community to stay up to date with the latest developments in the field, ESMO has expanded its portfolio of journals.

Society Updates Society Updates

Supporting Oncologists at the Point of Care: ESMO Living Guidelines

ESMO launched the ESMO Living Guidelines, a new tool designed to make the ESMO Clinical Practice Guidelines (CPGs) easier to use in oncologists’ routine clinical practice and support optimal decision-making in a rapidly evolving medical field

Society Updates Society Updates

2023 ESMO Breast Cancer Award Recipient Announced

The European Society for Medical Oncology (ESMO) has announced today that the 2023 ESMO Breast Cancer Award is bestowed to Sara A. Hurvitz for her remarkable contributions to breast cancer clinical and laboratory-based research

Society Updates Society Updates

2023 Heine H. Hansen Award Recipient Announced

The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) have announced today that the 2023 Heine H. Hansen Award is conferred on Paul Baas for his outstanding contribution to thoracic oncology research

More Society Updates
Daily Reporter

Extreme weather, extreme problems in oncology

This summer, photos of New York covered by smoke spread widely catching global attention on the massive wildfires in Canadian forests that caused that apocalyptic scenario. But why should we as oncologists be concerned about such events?

Daily Reporter

A growing community

Teresa Del Giudice is the 30,000th ESMO Member. In this interview she explains what motivated her to join the community.

Daily Reporter

On the horizon of translational research

Tumour agnostic targeted agents and ‘smarter’ dynamic designs are two major areas of interest leading to more patient-centric approaches in cancer care

Read the ESMO Daily Reporter

Congress Scientific Watch

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.